Keyphrases
Systematic Literature Review
100%
Disease Burden
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Current Treatment
33%
Economic Burden
33%
Humanistic Burden
33%
Epidemiology
22%
Physical Burden
22%
Psychosocial Burden
22%
Germany
11%
France
11%
Conference Proceedings
11%
Nineteen
11%
Rare Diseases
11%
Epidemiological Study
11%
On-state Current
11%
Health Systems
11%
Diagnostic Criteria
11%
Neurological Disorders
11%
Adverse Events
11%
Corticosteroids
11%
Intravenous Immunoglobulin (IVIg)
11%
Physical Function
11%
Immunomodulator
11%
Embase
11%
Treatment Costs
11%
Muscle Weakness
11%
Comprehensive Literature Review
11%
Search Terms
11%
PubMed
11%
Appropriate Treatment
11%
Indirect Costs
11%
Hospital Costs
11%
Sensory Function
11%
Cost-based
11%
Direct Costs
11%
Plasma Exchange
11%
Therapy Types
11%
Treatment Burden
11%
Treatment Administration
11%
Subcutaneous Immunoglobulin
11%
Biochemistry, Genetics and Molecular Biology
Immunoglobulin
100%
Prevalence
100%
Intravenous Immunoglobulin
100%
Medline
100%
Embase
100%
Corticosteroid Blood Level
100%
Medicine and Dentistry
Systematic Review
100%
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Diseases
100%
Cohort Effect
22%
Health Care Cost
22%
Prevalence
11%
Muscle Weakness
11%
Adverse Event
11%
Neurologic Disease
11%
Rare Disease
11%
Immunomodulating Agent
11%
Intravenous Immunoglobulin Therapy
11%
Immunosuppressant
11%
Plasma Exchange
11%
Diagnostic Criterion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Diseases
100%
Intravenous Therapy
11%
Rare Disease
11%
Neurologic Disease
11%
Prevalence
11%
Adverse Event
11%
Immunomodulating Agent
11%
Immunosuppressive Agent
11%
Muscle Weakness
11%
Immunology and Microbiology
Chronic Inflammatory Demyelinating Polyneuropathy
100%
Cohort Effect
22%
Immunomodulating Drugs
11%
Intravenous Immunoglobulin Therapy
11%
Prevalence
11%
Medline
11%
Embase
11%
Immunosuppressant
11%
Corticosteroid Blood Level
11%
Muscle
11%
Immunoglobulin
11%